Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2025
Public Summary Documents – July 2025 PBAC meeting
31 October 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2025 PBAC ...
Posted by Michael Wonder on 31 Oct 2025
ICER publishes final evidence report on treatment for non-cystic fibrosis bronchiectasis
30 October 2025 - Independent appraisal committee voted unanimously on the positive net health benefit of brensocatib; but current pricing ...
Posted by Michael Wonder on 29 Oct 2025
ICER publishes evidence report on treatments for obesity
29 October 2025 - All three drugs result in substantial weight loss; the therapies are cost effective, but the very ...
Posted by Michael Wonder on 20 Oct 2025
ICER releases draft evidence report on treatment for smoking cessation
20 October 2025 - Public comment period now open until 17 November 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 10 Oct 2025
DUSC utilisation analysis public release documents (April 2025)
10 October 2025 - The utilisation analysis public release documents from the April 2025 DUSC meeting are now available. ...
Posted by Michael Wonder on 09 Sep 2025
ICER releases draft evidence report on treatments for obesity
9 September 2025 - Public comment period now open until 6 October 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 09 Sep 2025
ICER publishes evidence report on treatment for non-cystic fibrosis bronchiectasis
8 September 2025 - There are significant uncertainties regarding long term efficacy of brensocatib; ICER estimates that treatment would achieve ...
Posted by Michael Wonder on 29 Aug 2025
Public Summary Documents – May 2025 PBAC meeting
29 August 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2025 PBAC ...
Posted by Michael Wonder on 23 Jul 2025
ICER releases draft evidence report on treatment for non-cystic fibrosis bronchiectasis
23 July 2025 - Public comment period now open until 19 August 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 18 Jul 2025
Public Summary Documents (first time decisions not to recommend and deferrals) – March 2025 PBAC meeting
18 July 2025 - The Public Summary Documents (first-time decisions not to recommend and deferrals) from the March 2025 PBAC ...
Posted by Michael Wonder on 18 Jul 2025
Outcome statement - June 2025 DUSC meeting
18 July 2025 - The outcome statement from the June 2025 DUSC meeting is now available. ...
Posted by Michael Wonder on 04 Jul 2025
Public Summary Documents - March 2025 PBAC meeting
4 July 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2025 ...
Posted by Michael Wonder on 03 Jul 2025
Release of provisional recommendations for expert advisory committees
1 July 2025 - We’re improving our processes, so that people can understand the outcome of expert advice to PHARMAC earlier. ...
Posted by Michael Wonder on 12 Jun 2025
EMA 2024 annual report is published
10 June 2025 - The EMA’s annual report 2024 published today gives insights into the Agency’s strategic priorities and contributions ...
Posted by Michael Wonder on 29 May 2025
ICER publishes evidence report on treatment for secondary progressive multiple sclerosis
29 May 2025 - There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve ...